友芝友生物-B（02496.HK）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

上市公司26.43%
个人与内部人士19.52%
私营企业19.29%
公众及其他10.34%
其他24.41%

主要股东

主要股东最新
股东
CSPC Pharmaceutical Group Limited	26.43%	5,124.18 万	0.00%	+0	2025/12/31
Qian YuanNon-Executive Director	10.52%	2,039.99 万	0.00%	+0	2026/06/11
Wuhan YZY Biopharma Co., Ltd, ESOP	8.66%	1,679.27 万	0.00%	+0	2026/06/11
Tongde Qianyuan (Beijing) Investment Management Co., Ltd.	7.14%	1,384.37 万	0.00%	+0	2026/03/30
Nanjing Caizhi No. 2 Enterprise Management Partnership	5.99%	1,162.04 万	0.00%	+0	2026/03/30
Hongfeng ZhouNon-Executive Director	5.26%	1,019.99 万	0.00%	+0	2026/03/30
Wuhan Optics Valley Industrial Investment Co., Ltd.	4.27%	828.60 万	0.00%	+0	2025/12/31
Long Star Growth Group Limited	4.08%	791.65 万	0.00%	+0	2025/12/31
Hainan Boyou Enterprise Management Consulting Center (Limited Partnership)	3.93%	762.65 万	0.00%	+0	2025/12/31
Ningbo Meishan Bonded Port Area Guangrui Hongxiang Equity Investment Partnership (Limited Partnershi	3.71%	719.68 万	0.00%	+0	2025/12/31
Wuhan Guanggu High-Tech Industry Investment Co., Ltd.	3.61%	700.00 万	0.00%	+0	2025/12/31
Pengfei ZhouChairman of the Board & CEO	3.54%	686.97 万	0.00%	+0	2026/03/30
Gongqingcheng Huiyou Xingyao Phase Ii Equity Investment Partnership (Limited Partnership)	1.57%	303.83 万	0.00%	+0	2026/03/30
Wuhan Optics Valley Growth Venture Capital Management Co., Ltd.	0.72%	140.00 万	0.00%	+0	2025/12/31
Hongwei GuoFormer Non-Executive Director	0.19%	37.01 万	0.00%	+0	2026/03/30